According to the latest data from the Hong Kong Stock Exchange, on September 21, JPMorgan reduced its holdings in Pharmaron (03759) by 1,124,839 shares at a price of HK$30.3712 per share, for a total amount of approximately HK$34.16 million.
Following the reduction, its latest shareholding stands at approximately 53.22 million shares, representing a latest stake of 14.78%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.